Matthew Heath

Company: Allergy Therapeutics

Job title: Principal Scientist, Innovation & Product Development

Seminars:

Developing Proof of Concept for a Virus-Like Particle Single Allergen Approach 11:00 am

Genetic fusion design of a peanut allergen-VLP vaccine Displaying peanut allergens on VLPs reduces its reactogenicity Single allergen combined with VLPs protects against a complex peanut extract First clinical study using novel VLPs against peanut allergy now plannedRead more

day: Day One